The phase 3 PhALLCON trial showed a trend toward improved EFS in patients with Ph+ newly diagnosed ALL when treated with ponatinib compared with imatinib.
A review of the importance family, friends, and a support system have on the cancer journey and survival outcomes for young adults with cancer.
At EAHAD 2023, researchers reported positive results from trials of patients with hemophilia A and B, including those who are difficult to treat.
High drug prices and ongoing shortages may prompt cancer patients to buy treatments online and fall prey to illegitimate pharmacies.